Menu
ÚHKT

Impaktované publikace

[1]

Gagelmann, N.; Bacigalupo, A.; Rambaldi, A.; Hoelzer, D.; Halter, J.; Sanz, J.; Bonifazi, F.; Meijer, E.; Itälä-Remes, M.; Marková, M.; et al.

Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a systematic review and meta-analysis

[rok vydání 2019, impact factor 24.799 ]

[2]

Machova Polakova, K.; Zizkova, H.; Zuna, J.; Motlova, E.; Hovorkova, L.; Gottschalk, A.; Glauche, I.; Koblihova, J.; Pecherkova, P.; Klamova, H.; Stastna Markova, M.; Srbova, D.; Benesova, A.; Polivkova, V.; et al.

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

[rok vydání 2020, impact factor 11.528 ]

[3]

Cruz-Garcia, L.; O'Brien, G.; Sipos, B.; Mayes, S.; Tichý, A.; Sirák, I.; Davídková, M.; Marková, M.; et al.

In vivo validation of alternative FDXR transcripts in human blood in response to ionizing radiation

[rok vydání 2020, impact factor 5.923 ]

[4]

Whiteside, S.; Chin, A.; Tripathi, G.; Dharmani-Khan, P.; Markova, M.; et al.

Curability and transferability of atopy with allogeneic hematopoietic cell transplantation

[rok vydání 2020, impact factor 5.483 ]

[5]

Brodska, H.; Drabek, T.; Malickova, K.; Kazda, A.; Vitek, A.; Zima, T.; Markova, M.

Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis : a prospective study

[rok vydání 2009, impact factor 4.931]

[6]

Hubacek, P.; Virgili, A.; Ward, K.N.; Pohlreich, D.; Keslova, P.; Goldova, B.; Markova, M.; Zajac, M.; Cinek, O.; Nacheva, E.P.; Sedlacek, P.; Cetkovsky, P.

HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis

[rok vydání 2009, impact factor 4.597]

[7]

Šťastná Marková, M.; Hamšíková, E.; Hainz, P.; Hubáček, P.; Kroutilová, M.; Kryštofová, J.; Ludvíková, V.; Musil, J.; Pecherková, P.; Saláková, M.; Šroller, V.;

Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of BK virus-associated haemorrhagic cystitis after allogeneic HSCT

[rok vydání 2021, impact factor 4.422 ]

[8]

Ostheim, P.; Tichy, A.; Sirak, I.; Davidkova, M.; Markova Stastna, M.; et al.

Overcoming challenges in human saliva gene expression measurements

[rok vydání 2020, impact factor 4.379 ]

[9]

Ostheim, P.; Alemu, S.W.; Tichy, A.; Sirak, I.; Davidkova, M.; Markova Stastna, M.; et al.

Examining potential confounding factors in gene expression analysis of human saliva and identifying potential housekeeping genes

[rok vydání 2022, impact factor 4.379 ]

[10]

Nemeckova, S.; Alexova-Zurkova, K.; Hainz, P.; Krystofova, J.; Mackova, J.; Roubalova, K.; Stastna-Markova, M.; Vrana, M.; Vydra, J.

Non-mutated nucleophosmin 1 is recognized by the CD8+ T lymphocytes of an AML patient after the transplantation of hematopoietic stem cells from an HLA-haploidentical donor

[rok vydání 2022, impact factor 3.677 ]

[11]

Valkova, V.; Vydra, J.; Markova, M.; Cerovska, E.; Vrana, M.; Marinov, I.; Cechova, H.; Cetkovsky, P.; Vitek, A.; Salek, C.

WT1 gene expression in peripheral blood before and after allogeneic stem cell transplantation is a clinically relevant prognostic marker in AML: a single-center 14-year experience

[rok vydání 2020, impact factor 3.231 ]

[12]

Markova, M.; Barker, J.N.; Miller, J.S.; Arora, M.; Wagner, J.E.; Burns, L.J.; MacMillan, M.L.; Douek, D.; DeFor, T.; Tan, Y.; Repka, T.; Blazar, B.R.; Weisdorf, D.J.

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation : a prospective randomized trial

[rok vydání 2008, impact factor 3.000]

[13]

Whiteside, S.; Markova, M.; Chin, A.; Lam, C.; Dharmani-Khan, P.; Modi, M.; Khan, F.; Storek, J.

Influence of chemotherapy on allergen-specific IgE

[rok vydání 2018, impact factor 2.932 ]

[14]

Kvasnička, J.; Marek, J.; Kvasnička, T.; Weiss, V.; Marková, M.; Štěpán, J.; Umlaufová, A.

Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement

[rok vydání 2006, impact factor 2.922]

[15]

Brodská, H.; Malíčková, K.; Adámková, V.; Benáková, H.; Marková Šťastná, M.; Zima, T.

Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis

[rok vydání 2012, impact factor 2.824 ]

[16]

Tichy, A.; Kabacik, S.; O’Brien, G.; Pejchal, J.; Sinkorova, Z.; Kmochova, A.; Sirak, I.; Malkova, A.; Beltran, C.G.; Gonzalez, J.; Grepl, J.; Majewski, M.; Ainsbury, E.; Zarybnicka, L.; Vachelova, J.; Zavrelova, A.; Davidkova, M.; Stastna, M.M.; et al.

The first in vivo multiparametric comparison of different radiation exposure biomarkers in human blood

[rok vydání 2018, impact factor 2.776 ]

[17]

Salaj, P.; Gurlich, R.; Svorcova, V.; Markova, M.; Cetkovsky, P.

Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa

[rok vydání 2008, impact factor 2.505]

[18]

Marková, M.; Brodská, H.; Malíčková, K.; Válková, V.; Cetkovský, P.; Kolář, M.; Haluzík, M.

Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients

[rok vydání 2014, impact factor 2.495 ]

[19]

Válková, V.; Schwarz, J.; Vítek, A.; Marková, M.; Pohlreich, D.; Benešová, K.; Michalová, K.; Cetkovský, P.; Trněný, M.

The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis

[rok vydání 2010, impact factor 2.475]

[20]

Klamová, H.; Marková, M.; Moravcová, J.; Šišková, M.; Cetkovský, P.; Machová Poláková, K.

Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery

[rok vydání 2009, impact factor 2.358]

Neimpaktované publikace

[1]

Marková, M.

Farmakoterapie v hematologii

[rok vydání 2011]